Skip to main content
. 2022 Apr 19;6:24715492221075444. doi: 10.1177/24715492221075444

Table 1.

Baseline Cohort Demographics.

Variable All Patients
(n = 10,302)
Median (IQR)
Age (years) 71 (12)
Hospital volume† 103 (141)
Number (%)
Male 4727 (45.88)
Race
 White 8835 (85.76)
 Black 333 (3.23)
 Asian / Pacific Islander 215 (2.09)
 Native American 51 (0.49)
 Other 777 (7.54)
 Unknown 91 (0.88)
Ethnicity
 Non-Hispanic 8900 (86.39)
 Hispanic 1309 (12.71)
 Unknown 93 (0.90)
Insurance
 Medicare 7433 (72.15)
 Private 1831 (17.77)
 Medi-Cal 393 (3.81)
 Workers’ compensation 518 (5.02)
 Other 127 (1.23)
Medical comorbidities
 Diabetes mellitus without complications 739 (7.17)
 Diabetes mellitus with complications 662 (6.43)
 Coronary atherosclerosis 719 (6.98)
 Morbid obesity 664 (6.45)
 COPD 700 (6.79)
 Chronic kidney disease, mild 682 (6.62)
 Chronic kidney disease, moderate 621 (6.03)
 Chronic kidney disease, severe 553 (5.37)
 Chronic kidney disease requiring dialysis 549 (5.33)
 Vascular disease 662 (6.43)
 Other circulatory disease 623 (6.05)
 Acute renal failure 650 (6.31)
 Cardio-respiratory failure 603 (5.85)
 Major depressive or bipolar disorder 636 (6.17)
 Major fracture (except skull) 574 (5.57)
 Hip fracture or dislocation 554 (5.38)
 Protein-calorie malnutrition 573 (5.56)
 Metastatic cancer or leukemia 544 (5.28)
 Complications of implants 708 (6.87)
 History of prior complications 595 (5.78)
 Osteoarthritis of hip or knee 737 (7.15)
 Osteoporosis 667 (6.47)
 History of bone/joint/muscle infection 589 (5.72)
Mean (SD)
Number of comorbidities 0.34 (1.19)

IQR = interquartile range; COPD = chronic obstructive pulmonary disease; SD = standard deviation

† Cases of primary aTSA performed between 10/1/2015 and 12/13/2017